OncoMed Pharmaceuticals Inc 4/A SEC Filings

Filed On	Filing
25 Mar 2016	Form 4/A: Hastings Paul J, Director Granted 170,000 Stock Option (Right to Buy)
04 Feb 2015	Form 4/A: Lewicki John A., EVP & Chief Scientific Officer Acquired 4,000 Stock Option (Right to Buy) (Option Exercise/Conversion)
12 Jan 2015	Form 4/A: Root Jonathan D, Director Holds 1,990,783 shares of Common Stock
03 Jul 2014	Form 4/A: Lewicki John A., EVP & Chief Scientific Officer Sold 4,000 shares ($98.3K)

Comments